The new era of imatinib mesylate

被引：0
|
作者：
Ohyashiki, K
Goldman, J
机构：
[1] Tokyo Med Univ, Dept Internal Med 1, Tokyo 1600023, Japan
[2] Univ London Imperial Coll Sci Technol & Med, London, England
来源：
LEUKEMIA RESEARCH | 2004年 / 28卷
关键词：
D O I：
10.1016/j.leukres.2003.10.012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 50 条
  • [1] Outcome of metastatic GIST in the era before imatinib mesylate
    Gold, JS
    Van der Zwan, SM
    Gonen, M
    Maki, RG
    Singer, S
    Brennan, MF
    Antonescu, CR
    DeMatteo, RP
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 29 - 29
  • [2] Use of imatinib mesylate in CML patients autografted in the pre-imatinib mesylate era: A single center experience.
    Liesveld, JL
    Nichols, D
    Ifthikharuddin, JJ
    Lancet, JE
    Abboud, CN
    [J]. BLOOD, 2002, 100 (11) : 473B - 473B
  • [3] Excellent outcomes of children with CML treated with imatinib mesylate compared to that in pre-imatinib era
    Muramatsu, Hideki
    Takahashi, Yoshiyuki
    Sakaguchi, Hirotoshi
    Shimada, Akira
    Nishio, Nobuhiro
    Hama, Asahito
    Doisaki, Sayoko
    Yagasaki, Hiroshi
    Matsumoto, Kimikazu
    Kato, Koji
    Kojima, Seiji
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (02) : 186 - 191
  • [4] Excellent outcomes of children with CML treated with imatinib mesylate compared to that in pre-imatinib era
    Hideki Muramatsu
    Yoshiyuki Takahashi
    Hirotoshi Sakaguchi
    Akira Shimada
    Nobuhiro Nishio
    Asahito Hama
    Sayoko Doisaki
    Hiroshi Yagasaki
    Kimikazu Matsumoto
    Koji Kato
    Seiji Kojima
    [J]. International Journal of Hematology, 2011, 93 : 186 - 191
  • [5] Imatinib mesylate for melanoma: Will a new target be revealed?
    Grossman, D
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (06) : XI - XIII
  • [6] Imatinib mesylate -: A new pill for chronic myelogenous leukemia
    Parmar, KK
    King, RS
    [J]. CANCER PRACTICE, 2001, 9 (05) : 263 - 265
  • [7] Imatinib mesylate in chordoma
    Casali, PG
    Messina, A
    Stacchiotti, S
    Tamborini, E
    Crippa, F
    Gronchi, A
    Orlandi, R
    Ripamonti, C
    Spreafico, C
    Bertieri, R
    Bertulli, R
    Colecchia, M
    Fumagalli, E
    Greco, A
    Grosso, F
    Olmi, P
    Pierotti, MA
    Pilotti, S
    [J]. CANCER, 2004, 101 (09) : 2086 - 2097
  • [8] The role of surgery in the management of gastrointestinal stromal tumors (GISTs) in the era of imatinib mesylate effectiveness
    Kosmadakis, N
    Visvardis, EE
    Kartsaklis, P
    Tsimara, M
    Chatziantoniou, A
    Panopoulos, L
    Erato, P
    Capsambelis, P
    [J]. SURGICAL ONCOLOGY-OXFORD, 2005, 14 (02): : 75 - 84
  • [9] A new therapeutic avenue for severe systemic sclerosis:: imatinib mesylate
    Taieb, A.
    Constans, J.
    Mahon, F. -X.
    [J]. REVUE DE MEDECINE INTERNE, 2008, 29 (03): : 173 - 175
  • [10] Imatinib - A new era in anticancer therapy
    Danchev, N.
    Nikolova, I.
    Momekov, G.
    [J]. BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2008, 22 (03) : 769 - 770
12345